MAPT and Alzheimer disease: Although we lack rigorous clinical data describing differences in plaques between AD and MxD, our data is consistent with findings in the Honolulu Aging Study showing increased dementia risk developing in cognitively normal men with vascular pathology who were found to have increased tau pathology but fewer neuritic amyloid plaques (Petrovitch et al., 2005).